Join to View Full Profile
3535 Olentangy River RdSte S1501Columbus, OH 43214
Phone+1 614-533-5500
Fax+1 614-533-0103
Dr. Nicholas is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jacqueline Nicholas is a neurologist in Columbus, OH and is affiliated with OhioHealth Riverside Methodist Hospital. She received her medical degree from University of Toledo College of Medicine and has been in practice 10 years. She specializes in neuroimmunology/multiple sclerosis and is experienced in multiple sclerosis, spasticity, neuroimmunology (multiple sclerosis), and neuromyelitis optica.
Education & Training
Ohio State University HospitalFellowship, Neuroimmunology & Multiple Sclerosis, 2011 - 2013
The Ohio State University College of Public HealthMPH, Clinical Translational Science, 2011 - 2013
UPMC Medical Education (Pittsburgh)Residency, Neurology, 2007 - 2011
The University of Toledo College of MedicineClass of 2007
Miami UniversityBA, Microbiology, Magna Cum Laude, 1999 - 2003
Certifications & Licensure
OH State Medical License 2011 - 2028
PA State Medical License 2007 - 2012
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2014, 2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2017
Publications & Presentations
PubMed
- Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).Emma C Tallantyre, Sarah M Planchon, Harriet Howard, John Mays, Nadia Frowd
Multiple Sclerosis. 2026-06-01 - 1 citationsEfficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, r...Stephen L Hauser, Gavin Giovannoni, Xavier Montalban, Jiwon Oh, Amit Bar-Or
Lancet. 2026-05-30 - 1 citationsTRACking health behavior in people with multiple sclerosis: Effects of a randomized trial on physical activity and working memory.Madhura Phansikar, Elizabeth Jean Duraney, Heena R Manglani, Anita Shankar, Christine Roberts
Rehabilitation Psychology. 2025-08-01
Press Mentions
The Challenge of Cognitive Changes in Multiple SclerosisOctober 1st, 2024- Columbus Man First in Nation to Receive New Multiple Sclerosis Treatment at OhioHealthMarch 8th, 2023
- Cannabis Use Common Among People with MSOctober 28th, 2021
Professional Memberships
- Member
- Consortium of Multiple Sclerosis CentersMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
